Opiant Pharmaceuticals/ US6837571081 /
3/1/2023 9:59:55 PM | Chg. - | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
20.63USD | - | 3,689 Turnover: 76,307.91 |
-Bid Size: - | -Ask Size: - | 20.95 | 20.60 |
GlobeNewswire
3/15/2022
Opiant Pharmaceuticals Announces Fourth Quarter and Full-Year 2021 Financial Results and Provides Co...
GlobeNewswire
3/10/2022
Opiant Pharmaceuticals to Participate in 32nd Oppenheimer Healthcare Conference
GlobeNewswire
3/7/2022
Opiant Pharmaceuticals to Report Fourth Quarter 2021 Financial Results and Host Conference Call and ...
GlobeNewswire
1/24/2022
Opiant Pharmaceuticals Announces Additional $2.2 million Funding Under BARDA Contract for OPNT003 Na...
GlobeNewswire
1/20/2022
Opiant Pharmaceuticals Announces First Patient Dosed in Phase 2 Trial of OPNT002, Nasal Naltrexone, ...
GlobeNewswire
1/20/2022
Correction: Opiant Pharmaceuticals Corrects Error in Issuing Duplicate Press Release Today
GlobeNewswire
11/11/2021
Opiant Pharmaceuticals Announces Third Quarter 2021 Financial Results and Provides Corporate Update
GlobeNewswire
11/10/2021
Opiant Pharmaceuticals to present at Jefferies Virtual London Healthcare Conference
GlobeNewswire
11/4/2021
Opiant Receives FDA Fast Track Designation for OPNT003, Nasal Nalmefene, for Treatment of Opioid Ove...
GlobeNewswire
11/3/2021
180 Life Sciences Corp. Names Quan A. Vu Chief Operating Officer/Chief Business Officer
GlobeNewswire
11/2/2021
Opiant Announces Publication of Manuscript Treatment of Overdose in the Synthetic Opioid Era in Peer...
GlobeNewswire
10/21/2021
Opiant Pharmaceuticals to Report Third Quarter 2021 Financial Results and Host Conference Call and W...
GlobeNewswire
8/5/2021
Opiant Pharmaceuticals Announces Second Quarter 2021 Financial Results and Provides Corporate Update
GlobeNewswire
7/22/2021
Opiant Pharmaceuticals to Report Second Quarter 2021 Financial Results and Host Conference Call and ...
GlobeNewswire
7/12/2021
Opiant Pharmaceuticals Announces Appointment of Matthew Ruth as Chief Commercial Officer
GlobeNewswire
7/6/2021
Opiant Pharmaceuticals Announces Positive Top-line Results of Confirmatory Pharmacokinetic (PK) Stud...
GlobeNewswire
5/24/2021
Opiant Pharmaceuticals to Present at the 2021 Jefferies Virtual Healthcare Conference
GlobeNewswire
5/18/2021
Opiant Pharmaceuticals to Hold Virtual 2021 Annual Shareholder Meeting on Tuesday, June 15, 2021 at ...
GlobeNewswire
5/11/2021
Opiant Pharmaceuticals Announces First Quarter 2021 Financial Results and Corporate Update